| scholarly article | Q13442814 |
| P356 | DOI | 10.1373/CLINCHEM.2007.097972 |
| P698 | PubMed publication ID | 18218722 |
| P50 | author | Tze Kin Lau | Q51980546 |
| P2093 | author name string | Rossa W K Chiu | |
| Y M Dennis Lo | |||
| Stephen S C Chim | |||
| Emily C W Hung | |||
| Tristan K F Shing | |||
| Tak-Yeung Leung | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 482-490 | |
| P577 | publication date | 2008-01-24 | |
| P1433 | published in | Clinical Chemistry | Q849687 |
| P1476 | title | Detection and characterization of placental microRNAs in maternal plasma | |
| P478 | volume | 54 |
| Q35644072 | A cluster of specified microRNAs in peripheral blood as biomarkers for metastatic non-small-cell lung cancer by stem-loop RT-PCR. |
| Q36362042 | A plasma mir-125a-5p as a novel biomarker for Kawasaki disease and induces apoptosis in HUVECs |
| Q36931355 | A serum microRNA signature as a prognostic factor for patients with advanced NSCLC and its association with tissue microRNA expression profiles |
| Q38912650 | A simple and highly sensitive fluorescence assay for microRNAs |
| Q44158395 | Aberrant expression of miR-196a in gastric cancers and correlation with recurrence |
| Q37386222 | Advances in circulating microRNAs as diagnostic and prognostic markers for ovarian cancer |
| Q37537123 | Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers |
| Q34883588 | An efficient and sensitive method for preparing cDNA libraries from scarce biological samples |
| Q38887384 | An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases |
| Q41875540 | Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). |
| Q37402025 | Analysis of organ-enriched microRNAs in plasma as an approach to development of Universal Screening Test: feasibility study |
| Q35023641 | Analysis of tissue and serum microRNA expression in patients with upper urinary tract urothelial cancer |
| Q29547772 | Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma |
| Q39274912 | Beyond circulating microRNA biomarkers: Urinary microRNAs in ovarian and breast cancer. |
| Q92817642 | Biosensors for early diagnosis of pancreatic cancer: a review |
| Q34291952 | Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies |
| Q42917130 | Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures |
| Q54976146 | Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise. |
| Q38165939 | Cardiovascular extracellular microRNAs: emerging diagnostic markers and mechanisms of cell-to-cell RNA communication |
| Q36216104 | Cell-Free miR-27a, a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer |
| Q39778751 | Cell-free fetal nucleic acids as prenatal biomarkers |
| Q38264253 | Cell-free microRNAs as cancer biomarkers: the odyssey of miRNAs through body fluids |
| Q34426839 | Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy |
| Q34233631 | Cell-free seminal mRNA and microRNA exist in different forms |
| Q60947611 | Change of Circulating and Tissue-Based miR-20a in Human Cancers and Associated Prognostic Implication: A Systematic Review and Meta-Analysis |
| Q40046304 | Characterization of a novel panel of plasma microRNAs that discriminates between Mycobacterium tuberculosis infection and healthy individuals |
| Q28131780 | Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases |
| Q45741384 | Characterization of placenta-specific microRNAs in fetal growth restriction pregnancy |
| Q37358895 | Circulating C19MC microRNAs in preeclampsia, gestational hypertension, and fetal growth restriction |
| Q98735793 | Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine |
| Q38864230 | Circulating Levels of Pregnancy-Associated, Placenta-Specific microRNAs in Pregnant Women With Placental Abruption |
| Q35612605 | Circulating MicroRNA-21 Is a Potential Diagnostic Biomarker in Gastric Cancer |
| Q36567001 | Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease |
| Q55515075 | Circulating MicroRNAs as Biomarkers in Diffuse Large B-cell Lymphoma: A Pilot Prospective Longitudinal Clinical Study. |
| Q38078373 | Circulating MicroRNAs as Biomarkers in Health and Disease |
| Q55209582 | Circulating MicroRNAs as Biomarkers of Gestational Diabetes Mellitus: Updates and Perspectives. |
| Q39375743 | Circulating MicroRNAs as Biomarkers of Prostate Cancer: The State of Play |
| Q99615002 | Circulating MicroRNAs as Novel Biomarkers for Osteoporosis and Fragility Fracture Risk: Is There a Use in Assessment Risk? |
| Q26738994 | Circulating MicroRNAs as Potential Molecular Biomarkers in Pathophysiological Evolution of Pregnancy |
| Q35054999 | Circulating MicroRNAs in maternal blood as potential biomarkers for fetal hypoxia in-utero |
| Q28080153 | Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers |
| Q26800274 | Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases |
| Q37209930 | Circulating Organ-Specific MicroRNAs Serve as Biomarkers in Organ-Specific Diseases: Implications for Organ Allo- and Xeno-Transplantation |
| Q57792385 | Circulating Plasma Extracellular Vesicles from Septic Mice Induce Inflammation via MicroRNA- and TLR7-Dependent Mechanisms |
| Q26745985 | Circulating biomarkers to monitor cancer progression and treatment |
| Q53402026 | Circulating chromosome 19 miRNA cluster microRNAs in pregnant women with severe pre-eclampsia. |
| Q47433188 | Circulating levels of maternal plasma cell-free miR-21 are associated with maternal body mass index and neonatal birth weight |
| Q36630868 | Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia |
| Q34140780 | Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression |
| Q36716377 | Circulating miR-583 and miR-663 Refer to ZHENG Differentiation in Chronic Hepatitis B. |
| Q54300178 | Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. |
| Q58611996 | Circulating miRNA measurements are reflective of cholesterol-based changes in rainbow trout (Oncorhynchus mykiss) |
| Q37447965 | Circulating miRNA profile in esophageal adenocarcinoma |
| Q35945187 | Circulating miRNA signatures of early pregnancy in cattle. |
| Q90479586 | Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine |
| Q42339128 | Circulating miRNAs as biomarkers of kidney disease |
| Q99562732 | Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets |
| Q34728385 | Circulating miRNAs in cancer: from detection to therapy |
| Q40965602 | Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis |
| Q36962750 | Circulating miRNAs: cell-cell communication function? |
| Q38045189 | Circulating miRNAs: reflecting or affecting cardiovascular disease? |
| Q37254246 | Circulating microRNA is a biomarker of pediatric Crohn disease. |
| Q36959754 | Circulating microRNA miR-323-3p as a biomarker of ectopic pregnancy. |
| Q41673524 | Circulating microRNAs and Bioinformatics Tools to Discover Novel Diagnostic Biomarkers of Pediatric Diseases. |
| Q39141563 | Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging? |
| Q37643903 | Circulating microRNAs as Potential Biomarkers of Infectious Disease |
| Q55361312 | Circulating microRNAs as Prognostic and Predictive Biomarkers in Patients with Colorectal Cancer. |
| Q36088154 | Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy |
| Q36931328 | Circulating microRNAs as biomarkers for the early diagnosis of childhood tuberculosis infection |
| Q26825718 | Circulating microRNAs as clinical biomarkers in the predictions of pregnancy complications |
| Q38102924 | Circulating microRNAs as novel biomarkers for diabetes mellitus |
| Q26744645 | Circulating microRNAs as potential biomarkers for diagnosis of congenital heart defects |
| Q50073076 | Circulating microRNAs as potential biomarkers in myasthenia gravis patients. |
| Q34542335 | Circulating microRNAs as specific biomarkers for breast cancer detection. |
| Q24652098 | Circulating microRNAs as stable blood-based markers for cancer detection |
| Q38776396 | Circulating microRNAs in acute and chronic exercise: more than mere biomarkers |
| Q27013716 | Circulating microRNAs in cancer: origin, function and application |
| Q86652747 | Circulating microRNAs in drug safety assessment for hepatic and cardiovascular toxicity: the latest biomarker frontier? |
| Q26862733 | Circulating microRNAs: a potential role in diagnosis and prognosis of acute myocardial infarction |
| Q38244277 | Circulating microRNAs: emerging biomarkers for diagnosis and prognosis in patients with gastrointestinal cancers. |
| Q38046599 | Circulating microRNAs: molecular microsensors in gastrointestinal cancer |
| Q87240747 | Circulating microRNAs: novel biomarkers for early detection of colorectal cancer |
| Q28081347 | Circulating microRNAs: potential biomarkers for common malignancies |
| Q36117667 | Circulating nucleic acids in plasma and serum: diagnosis and prognosis in cancer |
| Q34693160 | Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis |
| Q38184908 | Clinical relevance of circulating cell-free microRNAs in cancer |
| Q33720978 | Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs |
| Q26801503 | Combined Screening for Early Detection of Pre-Eclampsia |
| Q92155299 | Comparable expression of miR-let-7b, miR-21, miR-182, miR-145, and p53 in serum and cervical cells: Diagnostic implications for early detection of cervical lesions |
| Q34853050 | Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis |
| Q36693002 | Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations |
| Q60961942 | Contribution of regulatory T cells to immune tolerance and association of microRNA‑210 and Foxp3 in preeclampsia |
| Q84963968 | Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor |
| Q42288208 | Cross Talk between Adipose Tissue and Placenta in Obese and Gestational Diabetes Mellitus Pregnancies via Exosomes |
| Q92917120 | Cross-Roads to Drug Resistance and Metastasis in Breast Cancer: miRNAs Regulatory Function and Biomarker Capability |
| Q26796328 | Current State of Circulating MicroRNAs as Cancer Biomarkers |
| Q58586693 | Current and future perspectives of liquid biopsies in genomics-driven oncology |
| Q51244887 | Decreased Expression of Circulating miR-20a-5p in South African Women with Gestational Diabetes Mellitus. |
| Q36207643 | Depletion of tRNA-halves enables effective small RNA sequencing of low-input murine serum samples |
| Q24289207 | Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies |
| Q54434780 | Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. |
| Q21144210 | Detection of microRNA expression in human peripheral blood microvesicles |
| Q34277820 | Diagnostic role of microRNA expression profile in the serum of pregnant women with fetuses with neural tube defects |
| Q43539336 | Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer |
| Q64066128 | Differential expression of microRNA-411 and 376c is associated with hypertension in pregnancy |
| Q41183347 | Differential miR-346 and miR-582-3p Expression in Association with Selected Maternal and Fetal Complications |
| Q33626500 | Differential microRNA expression in human placentas of term intra-uterine growth restriction that regulates target genes mediating angiogenesis and amino acid transport |
| Q91689685 | Differential microRNA expression profile in the plasma of preeclampsia and normal pregnancies |
| Q36916522 | Differentially expressed microRNAs and affected biological pathways revealed by modulated modularity clustering (MMC) analysis of human preeclamptic and IUGR placentas. |
| Q34575372 | Differentially expressed microRNAs in maternal plasma for the noninvasive prenatal diagnosis of Down syndrome (trisomy 21). |
| Q34776270 | Distinct microRNAs expression profile in primary biliary cirrhosis and evaluation of miR 505-3p and miR197-3p as novel biomarkers. |
| Q42180937 | Do Neural Cells Communicate with Endothelial Cells via Secretory Exosomes and Microvesicles? |
| Q33561340 | Do miRNAs Play a Role in Fetal Growth Restriction? A Fresh Look to a Busy Corner |
| Q26864093 | Does regulation of skeletal muscle function involve circulating microRNAs? |
| Q21143782 | Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients |
| Q36088836 | Downregulation of Plasma MiR-142-3p and MiR-26a-5p in Patients With Colorectal Carcinoma |
| Q97681195 | EGF-mediated reduced miR-92a-1-5p controls HTR-8/SVneo cell invasion through activation of MAPK8 and FAS which in turn increase MMP-2/-9 expression |
| Q36384651 | Effects of sample processing and storage on the integrity of cell-free miRNAs in maternal plasma |
| Q41014418 | Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome |
| Q37295740 | Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the disease |
| Q93014743 | Elevated microRNA-141-3p in placenta of non-diabetic macrosomia regulate trophoblast proliferation |
| Q90032553 | Emerging role of microRNAs in dilated cardiomyopathy: evidence regarding etiology |
| Q34487177 | Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers |
| Q33620204 | Epigenetics in the placenta |
| Q36339879 | Evaluation of circulating miRNAs during late pregnancy in the mare. |
| Q35210574 | Evaluation of extraction kits and RT-qPCR systems adapted to high-throughput platform for circulating miRNAs |
| Q51344612 | Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma. |
| Q38757881 | Evidence and potential in vivo functions for biofluid miRNAs: From expression profiling to functional testing: Potential roles of extracellular miRNAs as indicators of physiological change and as agents of intercellular information exchange |
| Q38091950 | Exosomal miRNAs as Biomarkers for Prostate Cancer |
| Q92756215 | Exosomes-Associated DNA-New Marker in Pregnancy Complications? |
| Q36001906 | Exposure and fetal growth-associated miRNA alterations in the human placenta |
| Q41369374 | Expression and Regulatory Network Analysis of miR-140-3p, a New Potential Serum Biomarker for Autism Spectrum Disorder. |
| Q46404726 | Expression and trafficking of placental microRNAs at the feto-maternal interface |
| Q45908963 | Expression of miR-126 and its potential function in coronary artery disease. |
| Q35885559 | Expression of microRNAs in Horse Plasma and Their Characteristic Nucleotide Composition |
| Q37271870 | Expression patterns of placental microRNAs |
| Q35802914 | Expression profile of circulating microRNAs as a promising fingerprint for cervical cancer diagnosis and monitoring |
| Q35930887 | Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor |
| Q64445308 | Extracellular RNA in viral–host interactions: Thinking outside the cell |
| Q37690852 | Extracellular chromosome 21-derived microRNAs in euploid & aneuploid pregnancies |
| Q26797421 | Extracellular microRNAs as Biomarkers in Human Disease |
| Q64898517 | Extracellular microRNAs exhibit sequence-dependent stability and cellular release kinetics. |
| Q38648005 | Extracellular microRNAs in Membrane Vesicles and Non-vesicular Carriers. |
| Q27012889 | Extracellular nucleic acids in maternal circulation as potential biomarkers for placental insufficiency |
| Q26864365 | Extracellular small RNAs: what, where, why? |
| Q33555551 | Feasibility of placenta-derived mesenchymal stem cells as a tool for studying pregnancy-related disorders |
| Q37184985 | Feasibility of urinary microRNA profiling detection in intrahepatic cholestasis of pregnancy and its potential as a non-invasive biomarker |
| Q34702612 | First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension |
| Q51070173 | Follow-up of gestational trophoblastic disease/neoplasia via quantification of circulating nucleic acids of placental origin using C19MC microRNAs, hypermethylated RASSF1A, and SRY sequences. |
| Q34286705 | From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges |
| Q33697209 | Gene expression in the placenta: maternal stress and epigenetic responses |
| Q35837851 | Genetics of recurrent miscarriage: challenges, current knowledge, future directions |
| Q39902893 | Guest editor's introduction for BDQ special issue: 'Advanced Molecular Diagnostics for Biomarker Discovery'. |
| Q59101320 | High association between human circulating microRNA-497 and acute myocardial infarction |
| Q93155184 | Human Circulating miRNAs Real-time qRT-PCR-based Analysis: An Overview of Endogenous Reference Genes Used for Data Normalization |
| Q37031670 | Human placental trophoblasts confer viral resistance to recipient cells |
| Q84783822 | Identification of Pregnancy-Associated MicroRNAs in Maternal Plasma |
| Q36100719 | Identification of extracellular miRNA in archived serum samples by next-generation sequencing from RNA extracted using multiple methods |
| Q37093290 | Identification of four serum microRNAs from a genome-wide serum microRNA expression profile as potential non-invasive biomarkers for endometrioid endometrial cancer |
| Q36424106 | Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling |
| Q38661848 | Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy |
| Q37279280 | Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer |
| Q37799873 | Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis |
| Q58760266 | Impacts of bisphenol A (BPA) and phthalate exposures on epigenetic outcomes in the human placenta |
| Q55028545 | Improved sensitivity for detection of breast cancer by combination of miR-34a and tumor markers CA 15-3 or CEA. |
| Q53479241 | Increased Levels of Cell-Free miR-517a and Decreased Levels of Cell-Free miR-518b in Maternal Plasma Samples From Placenta Previa Pregnancies at 32 Weeks of Gestation. |
| Q48509845 | Intra-individual variation of miRNA expression levels in human plasma samples. |
| Q37686924 | Involvement of miRNAs in placental alterations mediated by oxidative stress. |
| Q40571835 | Isolation and characterization of vesicular and non-vesicular microRNAs circulating in sera of partially hepatectomized rats |
| Q41907437 | Isolation of small noncoding RNAs from human serum |
| Q21136096 | Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line |
| Q39101386 | Lung cancer and miRNAs: a possible remedy for anti-metastatic, therapeutic and diagnostic applications. |
| Q95840423 | MIR1246 in body fluids as a biomarker for pancreatic cancer |
| Q41640745 | Maternal Calorie Restriction Causing Uteroplacental Insufficiency Differentially Affects Mammalian Placental Glucose and Leucine Transport Molecular Mechanisms |
| Q38957150 | Maternal Circulating microRNAs and Pre-Eclampsia: Challenges for Diagnostic Potential |
| Q38662689 | Maternal alcohol consumption and altered miRNAs in the developing fetus: Context and future perspectives. |
| Q37722648 | Maternal and neonatal plasma microRNA biomarkers for fetal alcohol exposure in an ovine model |
| Q39713024 | Maternal plasma mRNA species in fetal heart defects: a potential for molecular screening |
| Q30377045 | Maternal plasma miRNAs as biomarkers during mid-pregnancy to predict later spontaneous preterm birth: a pilot study. |
| Q37194320 | Maternal plasma miRNAs expression in preeclamptic pregnancies |
| Q40508430 | Maternal pre-pregnancy body mass index and circulating microRNAs in pregnancy |
| Q50284988 | Mechanisms of vascular comorbidity in autoimmune diseases. |
| Q38212434 | Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients |
| Q36144748 | MiR-139-5p is associated with inflammatory regulation through c-FOS suppression, and contributes to the progression of primary biliary cholangitis. |
| Q34648569 | MiR-34a in age and tissue related radio-sensitivity and serum miR-34a as a novel indicator of radiation injury |
| Q89767324 | MiR-4435 is an UQCRB-related circulating miRNA in human colorectal cancer |
| Q38937055 | Micro RNAs: an arguable appraisal in medicine. |
| Q47206473 | MicroRNA Exocytosis by Vesicle Fusion in Neuroendocrine Cells |
| Q41663220 | MicroRNA Signaling in Embryo Development. |
| Q34836437 | MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia. |
| Q91938827 | MicroRNA changes in maternal serum from pregnancies complicated by twin-twin transfusion syndrome: A discovery study |
| Q37215297 | MicroRNA expression in lymphoid malignancies: new hope for diagnosis and therapy? |
| Q38489481 | MicroRNA in Ovarian Biology and Disease |
| Q26861675 | MicroRNA profiling: approaches and considerations |
| Q39148966 | MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. |
| Q58694956 | MicroRNA-141 and MicroRNA-200c Are Overexpressed in Granulosa Cells of Polycystic Ovary Syndrome Patients |
| Q46308935 | MicroRNA-141 is upregulated in preeclamptic placentae and regulates trophoblast invasion and intercellular communication. |
| Q35763637 | MicroRNA-34a inhibits human trophoblast cell invasion by targeting MYC. |
| Q35009884 | MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. |
| Q35198177 | MicroRNA-derived fragment length polymorphism assay |
| Q92163653 | MicroRNA-transcriptome networks in whole blood and monocytes of women undergoing preterm labour |
| Q26780358 | MicroRNAS in endometrial cancer: recent advances and potential clinical applications |
| Q59104729 | MicroRNAs and cardiovascular diseases |
| Q38184973 | MicroRNAs and human diseases: diagnostic and therapeutic potential |
| Q34696427 | MicroRNAs and their applications in kidney diseases |
| Q39857172 | MicroRNAs and their potential for translation in prostate cancer |
| Q37277090 | MicroRNAs as New Players for Diagnosis, Prognosis, and Therapeutic Targets in Breast Cancer |
| Q35599553 | MicroRNAs as potential biomarkers for noninvasive detection of fetal trisomy 21. |
| Q36553661 | MicroRNAs as potential biomarkers in human solid tumors |
| Q87509979 | MicroRNAs as potential diagnostic biomarkers in renal cell carcinoma |
| Q88934112 | MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic review |
| Q57299519 | MicroRNAs from plants to animals, do they define a new messenger for communication? |
| Q26801487 | MicroRNAs in Cancer: A Historical Perspective on the Path from Discovery to Therapy |
| Q36790358 | MicroRNAs in Human Placental Development and Pregnancy Complications |
| Q39220964 | MicroRNAs in Pregnancy and Gestational Diabetes Mellitus: Emerging Role in Maternal Metabolic Regulation |
| Q38005243 | MicroRNAs in adipose tissue: their role in adipogenesis and obesity |
| Q36176435 | MicroRNAs in body fluids--the mix of hormones and biomarkers |
| Q37766210 | MicroRNAs in cardiovascular diseases: biology and potential clinical applications |
| Q36118260 | MicroRNAs in placental health and disease |
| Q34045027 | MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels |
| Q33968783 | MicroRNAs transported by exosomes in body fluids as mediators of intercellular communication in cancer. |
| Q37255242 | MicroRNAs--micro in size but macro in function |
| Q38172587 | MicroRNAs: are they the missing link between hypoxia and pre-eclampsia? |
| Q35135542 | MicroRNAs: new players in IBD. |
| Q37737601 | MicroRNAs: novel biomarkers for gastrointestinal carcinomas |
| Q28391495 | MicroRNAs: their discovery, biogenesis, function and potential use as biomarkers in non-invasive prenatal diagnostics |
| Q34240588 | Microribonucleic acids and gastric cancer |
| Q57149236 | Molecular Biomarkers for Gestational Diabetes Mellitus |
| Q90209827 | Motor neuron-derived microRNAs cause astrocyte dysfunction in amyotrophic lateral sclerosis |
| Q26314697 | Movement of regulatory RNA between animal cells |
| Q21296770 | Next-generation sequencing of microRNAs for breast cancer detection |
| Q33800868 | No Significant Difference between Plasma miRNAs and Plasma-Derived Exosomal miRNAs from Healthy People |
| Q36248009 | Non-Lethal Endotoxin Injection: A Rat Model of Hypercoagulability |
| Q36117921 | Non-invasive prenatal diagnosis using cell-free fetal nucleic acids in maternal plasma: Progress overview beyond predictive and personalized diagnosis |
| Q35869283 | Nonfunctional ingestion of plant miRNAs in silkworm revealed by digital droplet PCR and transcriptome analysis |
| Q39261890 | Nonhuman primates as models for the discovery and development of radiation countermeasures. |
| Q37998943 | Noninvasive prenatal diagnosis empowered by high-throughput sequencing |
| Q37705437 | Noninvasive prenatal diagnosis using ccffDNA in maternal blood: state of the art. |
| Q92178883 | Ocular-Component-Specific miRNA Expression in a Murine Model of Lens-Induced Myopia |
| Q27028196 | Peripheral blood microRNAs: A novel tool for diagnosing disease? |
| Q38664319 | Physical exercise as an epigenetic modulator of brain plasticity and cognition. |
| Q38244018 | Placenta-derived exosomes and syncytiotrophoblast microparticles and their role in human reproduction: immune modulation for pregnancy success |
| Q35891731 | Placental Microparticles and MicroRNAs in Pregnant Women with Plasmodium falciparum or HIV Infection |
| Q37154584 | Placental miRNA expression profiles are associated with measures of infant neurobehavioral outcomes |
| Q37032214 | Placental microRNA expression in pregnancies complicated by superimposed pre‑eclampsia on chronic hypertension |
| Q30667824 | Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments |
| Q35987115 | Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma |
| Q34412367 | Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer |
| Q28741360 | Plasma miRNA as biomarkers for assessment of total-body radiation exposure dosimetry |
| Q35032320 | Plasma microRNA panel for minimally invasive detection of breast cancer |
| Q47110316 | Plasma microRNA profiling: Exploring better biomarkers for lymphoma surveillance. |
| Q37360422 | Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis |
| Q54456800 | Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. |
| Q39408199 | Platelets, circulating tumor cells, and the circulome. |
| Q62485272 | Point of care testing for infectious diseases |
| Q34121527 | Polymorphism in miRNA-1 target site and circulating miRNA-1 phenotype are associated with the decreased risk and prognosis of coronary artery disease |
| Q38232818 | Post- harvest consideration factors for microRNA research in cellular, tissue, serum and plasma samples |
| Q41682953 | Pre-storage centrifugation conditions have significant impact on measured microRNA levels in biobanked EDTA plasma samples. |
| Q37312671 | Predictive value of miR-210 as a novel biomarker for pre-eclampsia: a systematic review protocol |
| Q38718486 | Profiling cell-free and circulating miRNA: a clinical diagnostic tool for different cancers. |
| Q40477629 | Prospective validation of a blood-based 9-miRNA profile for early detection of breast cancer in a cohort of women examined by clinical mammography. |
| Q60046068 | Quantum Dot Based Nano-Biosensors for Detection of Circulating Cell Free miRNAs in Lung Carcinogenesis: From Biology to Clinical Translation |
| Q40357256 | RNA-mediated communication between helminths and their hosts: The missing links. |
| Q33999840 | Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer |
| Q28070336 | Roles of MicroRNA across Prenatal and Postnatal Periods |
| Q34999442 | Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection |
| Q92550520 | Scenario and future prospects of microRNAs in gastric cancer: A review |
| Q33728084 | Selective release of microRNA species from normal and malignant mammary epithelial cells |
| Q28817525 | Selective release of muscle-specific, extracellular microRNAs during myogenic differentiation |
| Q40105485 | Serum MicroRNA Levels as a Noninvasive Diagnostic Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Liver Fibrosis |
| Q35853196 | Serum MicroRNAs as Diagnostic Biomarkers for Macrosomia |
| Q36310416 | Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B |
| Q48346052 | Serum miR-146a, miR-155, and miR-210 as potential markers of Graves' disease. |
| Q34075488 | Serum microRNA expression profile distinguishes enterovirus 71 and coxsackievirus 16 infections in patients with hand-foot-and-mouth disease |
| Q36671959 | Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma |
| Q53089445 | Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients. |
| Q59532173 | Serum microRNA profiles in cats with hypertrophic cardiomyopathy |
| Q39147491 | Serum microRNA-195 is down-regulated in breast cancer: a potential marker for the diagnosis of breast cancer |
| Q21144238 | Serum microRNAs are promising novel biomarkers |
| Q34408233 | Serum microRNAs as non-invasive biomarkers for cancer |
| Q34704614 | Serum microRNAs profile from genome-wide serves as a fingerprint for diagnosis of acute myocardial infarction and angina pectoris |
| Q42570948 | Serum microRNAs: A new diagnostic method for colorectal cancer |
| Q35344075 | Signaling by exosomal microRNAs in cancer. |
| Q33868166 | Small Molecule, Big Prospects: MicroRNA in Pregnancy and Its Complications |
| Q55039327 | Small RNA profiling of low biomass samples: identification and removal of contaminants. |
| Q42423819 | Some cautionary notes on the petite "Holy Grail" of molecular diagnostics |
| Q33822089 | Sources and Functions of Extracellular Small RNAs in Human Circulation |
| Q36267323 | Stability of Circulating Blood-Based MicroRNAs - Pre-Analytic Methodological Considerations |
| Q26771750 | Subclinical Detection of Diabetic Cardiomyopathy with MicroRNAs: Challenges and Perspectives |
| Q90399991 | Surveillance of Tumour Development: The Relationship Between Tumour-Associated RNAs and Ribonucleases |
| Q33870546 | Syncytiotrophoblast derived extracellular vesicles transfer functional placental miRNAs to primary human endothelial cells |
| Q35108587 | Syncytiotrophoblast vesicles show altered micro-RNA and haemoglobin content after ex-vivo perfusion of placentas with haemoglobin to mimic preeclampsia |
| Q38641003 | Systematic Selection of Reference Genes for the Normalization of Circulating RNA Transcripts in Pregnant Women Based on RNA-Seq Data |
| Q34230033 | Systematic identification of spontaneous preterm birth-associated RNA transcripts in maternal plasma |
| Q27004655 | Systemic mirnas as potential biomarkers for malignancy |
| Q93052439 | The Current State of MicroRNAs as Restenosis Biomarkers |
| Q35921812 | The Function of TrophomiRs and Other MicroRNAs in the Human Placenta |
| Q37539064 | The Lin28/Let-7 system in early human embryonic tissue and ectopic pregnancy. |
| Q92852980 | The Role of Epigenetics in Placental Development and the Etiology of Preeclampsia |
| Q90224429 | The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications |
| Q98885228 | The Role of Exosomes in the Crosstalk between Adipocytes and Liver Cancer Cells |
| Q35667241 | The Role of RNAs and microRNAs in Non-Invasive Prenatal Diagnosis |
| Q88998651 | The Roles of MicroRNAs in Stroke: Possible Therapeutic Targets |
| Q35888026 | The biology of circulating microRNAs in cardiovascular disease. |
| Q38115783 | The complexity, function and applications of RNA in circulation |
| Q54997659 | The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform |
| Q40208718 | The expression level of C19MC miRNAs in early pregnancy and in response to viral infection |
| Q38480828 | The implications on clinical diagnostics of using microRNA-based biomarkers in exercise. |
| Q39308255 | The imprinted H19 gene regulates human placental trophoblast cell proliferation via encoding miR-675 that targets Nodal Modulator 1 (NOMO1). |
| Q35482938 | The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction |
| Q28083742 | The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy |
| Q36603037 | The mix of two worlds: non-coding RNAs and hormones |
| Q36378178 | The omniscient placenta: Metabolic and epigenetic regulation of fetal programming |
| Q88645051 | The placental gateway of maternal transgenerational epigenetic inheritance |
| Q31076809 | The potential of circulating extracellular small RNAs (smexRNA) in veterinary diagnostics-Identifying biomarker signatures by multivariate data analysis |
| Q64080546 | The role of NUDT21 in microRNA-binging sites of EZH2 gene increases the of risk preeclampsia |
| Q38361340 | The role of microRNAs in equine medicine: a review. |
| Q38745324 | The role of microRNAs in metal carcinogen-induced cell malignant transformation and tumorigenesis |
| Q30363613 | Toward reliable biomarker signatures in the age of liquid biopsies - how to standardize the small RNA-Seq workflow |
| Q37402146 | Transcellular chaperone signaling: an organismal strategy for integrated cell stress responses |
| Q21131238 | Trash or Treasure: extracellular microRNAs and cell-to-cell communication |
| Q39160222 | Tumor suppressive miR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma |
| Q38187323 | Tumor-associated circulating microRNAs as biomarkers of cancer. |
| Q89892838 | Two-step magnetic bead-based (2MBB) techniques for immunocapture of extracellular vesicles and quantification of microRNAs for cardiovascular diseases: A pilot study |
| Q35683637 | Unraveling the Mystery of Cancer by Secretory microRNA: Horizontal microRNA Transfer between Living Cells |
| Q55070791 | Upregulation of microRNA processing enzymes Drosha and Dicer in gestational diabetes mellitus. |
| Q34525152 | Urinary microRNA-10a and microRNA-30d serve as novel, sensitive and specific biomarkers for kidney injury |
| Q36519142 | Use of biomarkers for assessing radiation injury and efficacy of countermeasures |
| Q38714212 | Viruses and the placenta: the essential virus first view |
| Q34648245 | miR-141 contributes to fetal growth restriction by regulating PLAG1 expression |
| Q47726472 | miR-149 in Human Cancer: A Systemic Review |
| Q33941190 | miR-16 and miR-21 expression in the placenta is associated with fetal growth |
| Q38746706 | miR-346 and miR-582-3p-regulated EG-VEGF expression and trophoblast invasion via matrix metalloproteinases 2 and 9. |
| Q54233098 | miRNA expression profiles determined in maternal sera of patients with HELLP syndrome. |
| Q38503471 | miRNA expression profiling in formalin-fixed and paraffin-embedded placental tissue samples from pregnancies with severe preeclampsia |
| Q38447020 | miRNA in multiple sclerosis: search for novel biomarkers |
| Q44687356 | miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer |
| Q37211784 | miRNA: The nemesis of gastric cancer (Review). |
| Q38730644 | miRNAs and High-Density Lipoprotein metabolism |
| Q34119176 | miRNAs in circulation: mirroring bone conditions? |
| Q38519325 | miRNAs in pregnancy-related complications |
| Q38667018 | microRNA and Ovarian Cancer |
| Q48562097 | microRNA in Human Reproduction. |
| Q38449368 | microRNAs Databases: Developmental Methodologies, Structural and Functional Annotations |
| Q37918622 | microRNAs as peripheral blood biomarkers of cardiovascular disease. |
| Q26778918 | microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment |
| Q36905867 | microRNAs: innovative targets for cerebral ischemia and stroke. |
Search more.